Skip to main content
SpringerLink
Log in
Book cover

Acute Endocrinology pp 167–180Cite as

The Dynamic Neuroendocrine Response to Critical Illness

  • Chapter

Part of the book series: Contemporary Endocrinology ((COE))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Van den Berghe G, de Zegher F, Bouillon R. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998; 83(6):1827–1834.

    Article  PubMed  Google Scholar 

  2. Weekers F, Van Herck E, Coopmans W et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology 2002; 143(3):764–774.

    Article  CAS  PubMed  Google Scholar 

  3. Takala J, Ruokonen E, Webster NR et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341(11):785–792.

    Article  CAS  PubMed  Google Scholar 

  4. Roberts I, Yates D, Sandercock P et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004; 364(9442):1321–1328.

    Article  PubMed  Google Scholar 

  5. Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Veldhuis JD. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab 2000; 85(1):183–192.

    Article  PubMed  Google Scholar 

  6. Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984; 114(5):1537–1545.

    Article  CAS  PubMed  Google Scholar 

  7. Howard AD, Feighner SD, Cully DF et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273(5277):974–977.

    Article  CAS  PubMed  Google Scholar 

  8. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402(6762):656–660.

    Article  CAS  PubMed  Google Scholar 

  9. Ross R, Miell J, Freeman E et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol (Oxf) 1991; 35(1):47–54.

    Article  CAS  Google Scholar 

  10. Baxter RC, Hawker FH, To C, Stewart PM, Holman SR. Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. Growth Horm IGF Res 1998; 8(6):455–463.

    Article  CAS  PubMed  Google Scholar 

  11. Hermansson M, Wickelgren RB, Hammarqvist F et al. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery. J Clin Endocrinol Metab 1997; 82(2):421–428.

    Article  CAS  PubMed  Google Scholar 

  12. Defalque D, Brandt N, Ketelslegers JM, Thissen JP. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. Am J Physiol 1999; 276(3 Pt 1):E565–E572.

    CAS  PubMed  Google Scholar 

  13. Van den Berghe G, de Zegher F, Veldhuis JD et al. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab 1997; 82(2):590–599.

    Article  PubMed  Google Scholar 

  14. Van den Berghe G, de Zegher F, Baxter RC et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab 1998; 83(2):309–319.

    Article  PubMed  Google Scholar 

  15. Van den Berghe G, Wouters P, Weekers F et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 1999; 84(4):1311–1323.

    Article  PubMed  Google Scholar 

  16. Langouche L, Vanhorebeek I, Van den Berghe G. Therapy insight: the effect of tight glycemic control in acute illness. Nat Clin Pract Endocrinol Metab 2007; 3(3):270–278.

    Article  PubMed  Google Scholar 

  17. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 1993; 91(2):391–396.

    Article  CAS  PubMed  Google Scholar 

  18. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001; 81(3):1097–1142.

    CAS  PubMed  Google Scholar 

  19. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23(1):38–89.

    Article  CAS  PubMed  Google Scholar 

  20. Friesema EC, Jansen J, Visser TJ. Thyroid hormone transporters. Biochem Soc Trans 2005; 33(Pt 1):228–232.

    CAS  PubMed  Google Scholar 

  21. Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab 2001; 86(9):4198–4205.

    Article  CAS  PubMed  Google Scholar 

  22. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 2000; 143(1):1–13.

    Article  PubMed  Google Scholar 

  23. Romijn JA, Wiersinga WM. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab 1990; 70(1):35–42.

    Article  CAS  PubMed  Google Scholar 

  24. Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995; 23(1):78–83.

    Article  CAS  PubMed  Google Scholar 

  25. Rothwell PM, Udwadia ZF, Lawler PG. Thyrotropin concentration predicts outcome in critical illness. Anaesthesia 1993; 48(5):373–376.

    Article  CAS  PubMed  Google Scholar 

  26. Boelen A, Platvoet-ter Schiphorst MC, Bakker O, Wiersinga WM. The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice. J Endocrinol 1995; 146(3):475–483.

    Article  CAS  PubMed  Google Scholar 

  27. Van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990; 71(6):1567–1572.

    Article  PubMed  Google Scholar 

  28. Van der Poll T, Van Zee KJ, Endert E et al. Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J Clin Endocrinol Metab 1995; 80(4):1341–1346.

    Article  PubMed  Google Scholar 

  29. Van der Poll T, Endert E, Coyle SM, Agosti JM, Lowry SF. Neutralization of TNF does not influence endotoxininduced changes in thyroid hormone metabolism in humans. Am J Physiol 1999; 276(2 Pt 2):R357–R362.

    PubMed  Google Scholar 

  30. Lim CF, Docter R, Visser TJ et al. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab 1993; 76(5):1165–1172.

    Article  CAS  PubMed  Google Scholar 

  31. Gardner DF, Kaplan MM, Stanley CA, Utiger RD. Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 1979; 300(11):579–584.

    Article  CAS  PubMed  Google Scholar 

  32. De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999; 84(1):151–164.

    Article  PubMed  Google Scholar 

  33. Van den Berghe G, de Zegher F, Veldhuis JD et al. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clin Endocrinol (Oxf) 1997; 47(5):599–612.

    Article  Google Scholar 

  34. Peeters RP, Wouters PJ, van Toor H, Kaptein E, Visser TJ, Van den Berghe G. Serum rT3 and T3/rT3 are prognostic markers in critically ill patients and are associated with post-mortem tissue deiodinase activities. J Clin Endocrinol Metab 2005; 90(8):4559–4565.

    Article  CAS  PubMed  Google Scholar 

  35. Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 1997; 82(12):4032–4036.

    Article  CAS  PubMed  Google Scholar 

  36. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17(10):975–978.

    Article  CAS  PubMed  Google Scholar 

  37. Van den Berghe G, de Zegher F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 1994; 41(6):731–737.

    Article  Google Scholar 

  38. Faglia G, Ferrari C, Beck-Peccoz P, Spada A, Travaglini P, Ambrosi B. Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal subjects. Horm Metab Res 1973; 5(4):289–292.

    Article  CAS  PubMed  Google Scholar 

  39. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 2003; 88(7):3202–3211.

    Article  CAS  PubMed  Google Scholar 

  40. Mebis L, Langouche L, Visser TJ, Van den Berghe G. The Type II Iodothyronine Deiodinase Is Up-Regulated in Skeletal Muscle during Prolonged Critical Illness. J Clin Endocrinol Metab 2007; 92(8):3330–3333.

    Article  CAS  PubMed  Google Scholar 

  41. Weekers F, Michalaki M, Coopmans W et al. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. Endocrinology 2004; 145(1):205–213.

    Article  CAS  PubMed  Google Scholar 

  42. Debaveye Y, Ellger B, Mebis L et al. Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2. Endocrinology 2005; 146(12):5604–5611.

    Article  CAS  PubMed  Google Scholar 

  43. Thijssen-Timmer DC, Peeters RP, Wouters P et al. Thyroid hormone receptor isoform expression in livers of critically ill patients. Thyroid 2007; 17(2):105–112.

    Article  CAS  PubMed  Google Scholar 

  44. Bettendorf M, Schmidt KG, Grulich-Henn J, Ulmer HE, Heinrich UE. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000; 356(9229):529–534.

    Article  CAS  PubMed  Google Scholar 

  45. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  46. Spratt DI. Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated? Best Pract Res Clin Endocrinol Metab 2001; 15(4):479–494.

    Article  CAS  PubMed  Google Scholar 

  47. Russell DH. New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol Sci 1989; 10(1):40–44.

    Article  CAS  PubMed  Google Scholar 

  48. Samson WK, Taylor MM, Baker JR. Prolactin-releasing peptides. Regul Pept 2003; 114(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  49. Wang C, Chan V, Yeung RT. Effect of surgical stress on pituitary-testicular function. Clin Endocrinol (Oxf) 1978; 9(3):255–266.

    Article  CAS  Google Scholar 

  50. Wang C, Chan V, Tse TF, Yeung RT. Effect of acute myocardial infarction on pituitary-testicular function. Clin Endocrinol (Oxf) 1978; 9(3):249–253.

    Article  CAS  Google Scholar 

  51. Dong Q, Hawker F, McWilliam D, Bangah M, Burger H, Handelsman DJ. Circulating immunoreactive inhibin and testosterone levels in men with critical illness. Clin Endocrinol (Oxf) 1992; 36(4):399–404.

    Article  CAS  Google Scholar 

  52. Rivier C, Vale W, Brown M. In the rat, interleukin-1 alpha and -beta stimulate adrenocorticotropin and catecholamine release. Endocrinology 1989; 125(6):3096–3102.

    Article  CAS  PubMed  Google Scholar 

  53. Guo H, Calkins JH, Sigel MM, Lin T. Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis. Endocrinology 1990; 127(3):1234–1239.

    Article  CAS  PubMed  Google Scholar 

  54. Noel GL, Suh HK, Stone JG, Frantz AG. Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab 1972; 35(6):840–851.

    Article  CAS  PubMed  Google Scholar 

  55. Vogel AV, Peake GT, Rada RT. Pituitary-testicular axis dysfunction in burned men. J Clin Endocrinol Metab 1985; 60(4):658–665.

    Article  CAS  PubMed  Google Scholar 

  56. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985; 60(3):444–450.

    Article  CAS  PubMed  Google Scholar 

  57. Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine. Clin Endocrinol (Oxf) 1994; 41(5):563–569.

    Article  Google Scholar 

  58. Van den Berghe G, Weekers F, Baxter RC et al. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab 2001; 86(7):3217–3226.

    Article  PubMed  Google Scholar 

  59. Christeff N, Benassayag C, Carli-Vielle C, Carli A, Nunez EA. Elevated oestrogen and reduced testosterone levels in the serum of male septic shock patients. J Steroid Biochem 1988; 29(4):435–440.

    Article  CAS  PubMed  Google Scholar 

  60. Fourrier F, Jallot A, Leclerc L et al. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ Shock 1994; 43(4):171–178.

    CAS  PubMed  Google Scholar 

  61. Spratt DI, Morton JR, Kramer RS, Mayo SW, Longcope C, Vary CP. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Physiol Endocrinol Metab 2006; 291(3):E631–E638.

    Article  CAS  PubMed  Google Scholar 

  62. Devins SS, Miller A, Herndon BL, O'Toole L, Reisz G. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 1992; 20(12):1644–1649.

    Article  CAS  PubMed  Google Scholar 

  63. Ferrando AA, Sheffield-Moore M, Wolf SE, Herndon DN, Wolfe RR. Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med 2001; 29(10):1936–1942.

    Article  CAS  PubMed  Google Scholar 

  64. Angele MK, Ayala A, Cioffi WG, Bland KI, Chaudry IH. Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage. Am J Physiol 1998; 274(6 Pt 1):C1530–C1536.

    CAS  PubMed  Google Scholar 

  65. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348(8):727–734.

    Article  CAS  PubMed  Google Scholar 

  66. Burchard K. A review of the adrenal cortex and severe inflammation: quest of the "eucorticoid" state. J Trauma 2001; 51(4):800–814.

    Article  CAS  PubMed  Google Scholar 

  67. Pemberton PA, Stein PE, Pepys MB, Potter JM, Carrell RW. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 1988; 336(6196):257–258.

    Article  CAS  PubMed  Google Scholar 

  68. Hammond GL, Smith CL, Paterson NA, Sibbald WJ. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab 1990; 71(1):34–39.

    Article  CAS  PubMed  Google Scholar 

  69. Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001; 27(10):1584–1591.

    Article  CAS  PubMed  Google Scholar 

  70. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350(16):1629–1638.

    Article  CAS  PubMed  Google Scholar 

  71. Vanhorebeek I, Peeters RP, Vander PS et al. Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab 2006; 91(10):3803–3813.

    Article  CAS  PubMed  Google Scholar 

  72. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002; 122(5):1784–1796.

    Article  PubMed  Google Scholar 

  73. Finlay WE, McKee JI. Serum cortisol levels in severely stressed patients. Lancet 1982; 1(8286):1414–1415.

    Article  CAS  PubMed  Google Scholar 

  74. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337(8741):582–583.

    Article  CAS  PubMed  Google Scholar 

  75. Span LF, Hermus AR, Bartelink AK et al. Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med 1992; 18(2):93–96.

    Article  CAS  PubMed  Google Scholar 

  76. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283(8):1038–1045.

    Article  CAS  PubMed  Google Scholar 

  77. Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288(7):862–871.

    Article  CAS  PubMed  Google Scholar 

  78. Sam S, Corbridge TC, Mokhlesi B, Comellas AP, Molitch ME. Cortisol levels and mortality in severe sepsis. Clin Endocrinol (Oxf) 2004; 60(1):29–35.

    Article  CAS  Google Scholar 

  79. Bornstein SR, Chrousos GP. Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 1999; 84(5):1729–1736.

    Article  CAS  PubMed  Google Scholar 

  80. Vermes I, Beishuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab 2001; 15(4):495–511.

    Article  CAS  PubMed  Google Scholar 

  81. Barquist E, Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 1997; 42(1):27–31.

    Article  CAS  PubMed  Google Scholar 

  82. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004; 141(1):47–56.

    CAS  PubMed  Google Scholar 

  83. Annane D, Briegel J, Sprung CL. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348(21):2157–2159.

    Article  PubMed  Google Scholar 

  84. Van den Berghe G, Baxter RC, Weekers F et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 2002; 56(5):655–669.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care Medicine, University Hospital Gasthuisberg, Catholic University of Leuven, Leuven, Belgium

    Lies Langouche & Greet Van den Berghe

Authors
  1. Lies Langouche
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Greet Van den Berghe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Langouche, L., Van den Berghe, G. (2008). The Dynamic Neuroendocrine Response to Critical Illness. In: Acute Endocrinology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-177-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-177-6_8

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-176-9

  • Online ISBN: 978-1-60327-177-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation